Phase-3 clinical trial of dengue vaccine starts – The Times of India

Phase-3 clinical trial of dengue vaccine starts  The Times of IndiaPanacea Biotec shares up 5% as phase-3 trial of India’s first dengue vaccine ‘DengiAll’ begins  UpstoxICMR, Panacea Biotec begin first-ever phase 3 clinical trial of made-in-India dengue vaccine  The New Indian ExpressDengue vaccine: Phase-3 of trial begins in Rohtak  The Indian ExpressFirst-ever phase-three clinical trial for dengue vaccine initiated in India  The Economic Times Phase-3 clinical trial of dengue vaccine starts  The Times of IndiaPanacea Biotec shares up 5% as phase-3 trial of India’s first dengue vaccine ‘DengiAll’ begins  UpstoxICMR, Panacea Biotec begin first-ever phase 3 clinical trial of made-in-India dengue vaccine  The New Indian ExpressDengue vaccine: Phase-3 of trial begins in Rohtak  The Indian ExpressFirst-ever phase-three clinical trial for dengue vaccine initiated in India  The Economic Times  Top stories – Google News